>>MSCI – Two additions to MSCI Indonesia: Charoen Pokphand Indonesia (CPIN) and Kalbe Farma (KLBF). Estimated buying volume for CPIN is 43.5mn shares, for KLBF is 133mn shares.>>>
"إِنَّا مَكَّنَّا لَهُۥ فِى ٱلْأَرْضِ وَءَاتَيْنَهُ مِن كُلِّ شَىْءٍۢ سَبَبًۭا فَأَتْبَعَ سَبَبًا Sesungguhnya Kami telah memberi kekuasaan kepadanya di (muka) bumi, dan Kami telah memberikan kepadanya jalan (untuk mencapai) segala sesuatu, maka diapun menempuh suatu jalan." (QS. AL KAHFI:84-85)
>> Saham Agung Podomoro Dilepas Rp365 per Unit >>> INDY: After mkt close the major shareholders placed out a USD 200m block of stock, or about 10% of cap at 3675 (range 3600-3725) at a 5.7% discount. The placement was said to be 3X subscribed to.

My Family

Rabu, 25 Februari 2009

Mandiri Sekuritas Improved outlook, yet risks remain

Improved sales outlook. This year, the company expects its sales to grow by 13% - 14% yoy compared with 12% yoy last year as it believes that the sales of energy drink has levelled off (the sales for energy drink is reported to improve in 4Q08 vs -39.2% qoq average in the previous three quarters). Amid the current unfavorable economic condition, demand for nutrition and ethical products will remain resilient (both took up around 50-55% of the total sales and has grown by 16% and 21% CAGR, respectively! for the past three years), hence any recovery in sales from energy drink will make the targeted sales growth of 13% yoy easy to achieve, in our view. We therefore upgraded our sales growth assumption from previously 10% yoy to 12.6% yoy.

Upgrade TP to Rp600/share. We upgraded our forecast on KLBF on the back of higher sales growth and gross margin. We arrived at net profit of Rp749bn for FY09, an increase of 26.9% from our previous forecast. At the current price, KLBF is trading at 18.0% premium over the market PER compared with at-par valuation for its peers (during 2008, KLBF was also traded at par valuation to the market). Given KLBF’s lower size and EPS growth than its peers and the lingering risks over the company’s performance t! his year, such premium is unjustified, in our view. We believe the stock should be traded at 20% discount to the market, thus resulting in a new TP of Rp600/share at targeted market PER of 10.0x (vs TP of Rp355/share previously). Upgraded to neutral.

Tidak ada komentar:

Posting Komentar

Yahoo! Finance: Top Stories

Reuters: Business News

Insider Stories

CNBC Top News and Analysis

» Ekobiz

The Wall Street Journal

AnggunTraders.com

Commodity Online Metals News

Britama.com

Palm Oil Prices

Commodities-Markets-The Economic Times

Detikfinance

BusinessWeek.com -- Top News

Palm Oil HQ Daily Update

Business Times : marketwatch

VIVAnews - BISNIS

The Star Online: Business

Inilah.com -

Latest financial news - CNNMoney.com

Tempointeraktif.com - Bisnis

ChinaDaily > bizchina

Sindikasi economy.okezone.com

Commodity News

Bursa Rumor - Tempatnya Investor Saham Cari Berita

Financial Times - Financial markets news

Hellenic Shipping News

ANTARA - Ekonomi & Bisnis

Industrial Metals & Minerals Industry News

Republika Online - Ekonomi

Yahoo Commodities News